MX2021000475A - Isoxazol como agonista del receptor fxr. - Google Patents
Isoxazol como agonista del receptor fxr.Info
- Publication number
- MX2021000475A MX2021000475A MX2021000475A MX2021000475A MX2021000475A MX 2021000475 A MX2021000475 A MX 2021000475A MX 2021000475 A MX2021000475 A MX 2021000475A MX 2021000475 A MX2021000475 A MX 2021000475A MX 2021000475 A MX2021000475 A MX 2021000475A
- Authority
- MX
- Mexico
- Prior art keywords
- isoxazole
- receptor agonists
- fxr receptor
- fxr
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a compuestos de fórmula (I), a composiciones farmacéuticas de los mismos y a sus usos, en particular, en el tratamiento y/o prevención de enfermedades mediadas por el receptor FXR. (ver formula).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000007265A IT201800007265A1 (it) | 2018-07-17 | 2018-07-17 | Isossazoli come agonisti del recettore fxr |
| PCT/IB2019/056114 WO2020016801A1 (en) | 2018-07-17 | 2019-07-17 | Isoxazole as fxr receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021000475A true MX2021000475A (es) | 2021-06-08 |
Family
ID=63762897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021000475A MX2021000475A (es) | 2018-07-17 | 2019-07-17 | Isoxazol como agonista del receptor fxr. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11332450B2 (es) |
| EP (1) | EP3823960B1 (es) |
| JP (1) | JP2021530535A (es) |
| KR (1) | KR20210045390A (es) |
| CN (1) | CN112424173A (es) |
| BR (1) | BR112021000913A2 (es) |
| CA (1) | CA3106309A1 (es) |
| DK (1) | DK3823960T3 (es) |
| ES (1) | ES2932290T3 (es) |
| FI (1) | FI3823960T3 (es) |
| HR (1) | HRP20221450T1 (es) |
| HU (1) | HUE060708T2 (es) |
| IT (1) | IT201800007265A1 (es) |
| LT (1) | LT3823960T (es) |
| MX (1) | MX2021000475A (es) |
| PL (1) | PL3823960T3 (es) |
| PT (1) | PT3823960T (es) |
| RS (1) | RS63854B1 (es) |
| SI (1) | SI3823960T1 (es) |
| WO (1) | WO2020016801A1 (es) |
| ZA (1) | ZA202100513B (es) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60131967D1 (de) * | 2001-08-13 | 2008-01-31 | Phenex Pharmaceuticals Ag | Nr1h4-kern-rezeptor-bindende verbindungen |
| JP2006515838A (ja) * | 2002-11-22 | 2006-06-08 | スミスクライン ビーチャム コーポレーション | ファルネソイドｘ受容体アゴニスト |
| EP1894924A1 (en) * | 2006-08-29 | 2008-03-05 | Phenex Pharmaceuticals AG | Heterocyclic FXR binding compounds |
| EP2655368A1 (en) * | 2010-12-20 | 2013-10-30 | Irm Llc | Compositions and methods for modulating farnesoid x receptors |
| WO2017189663A1 (en) * | 2016-04-26 | 2017-11-02 | Enanta Pharmaceuticals, Inc. | Isoxazole derivatives as fxr agonists and methods of use thereof |
| US10144729B2 (en) * | 2016-05-18 | 2018-12-04 | Enanta Pharmaceuticals, Inc. | Isoxazole analogs as FXR agonists and methods of use thereof |
| WO2017201155A1 (en) * | 2016-05-18 | 2017-11-23 | Enanta Pharmaceuticals, Inc. | lSOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF |
-
2018
- 2018-07-17 IT IT102018000007265A patent/IT201800007265A1/it unknown
-
2019
- 2019-07-17 PL PL19769877.2T patent/PL3823960T3/pl unknown
- 2019-07-17 FI FIEP19769877.2T patent/FI3823960T3/fi active
- 2019-07-17 KR KR1020217003122A patent/KR20210045390A/ko unknown
- 2019-07-17 LT LTEPPCT/IB2019/056114T patent/LT3823960T/lt unknown
- 2019-07-17 CN CN201980048015.6A patent/CN112424173A/zh active Pending
- 2019-07-17 PT PT197698772T patent/PT3823960T/pt unknown
- 2019-07-17 MX MX2021000475A patent/MX2021000475A/es unknown
- 2019-07-17 HU HUE19769877A patent/HUE060708T2/hu unknown
- 2019-07-17 SI SI201930388T patent/SI3823960T1/sl unknown
- 2019-07-17 BR BR112021000913-2A patent/BR112021000913A2/pt unknown
- 2019-07-17 DK DK19769877.2T patent/DK3823960T3/da active
- 2019-07-17 US US17/260,596 patent/US11332450B2/en active Active
- 2019-07-17 CA CA3106309A patent/CA3106309A1/en active Pending
- 2019-07-17 WO PCT/IB2019/056114 patent/WO2020016801A1/en unknown
- 2019-07-17 HR HRP20221450TT patent/HRP20221450T1/hr unknown
- 2019-07-17 RS RS20221101A patent/RS63854B1/sr unknown
- 2019-07-17 EP EP19769877.2A patent/EP3823960B1/en active Active
- 2019-07-17 ES ES19769877T patent/ES2932290T3/es active Active
- 2019-07-17 JP JP2021502996A patent/JP2021530535A/ja active Pending
-
2021
- 2021-01-25 ZA ZA2021/00513A patent/ZA202100513B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11332450B2 (en) | 2022-05-17 |
| PT3823960T (pt) | 2022-12-07 |
| HRP20221450T1 (hr) | 2023-03-31 |
| DK3823960T3 (da) | 2022-12-05 |
| PL3823960T3 (pl) | 2023-03-20 |
| US20210269409A1 (en) | 2021-09-02 |
| FI3823960T3 (fi) | 2022-12-15 |
| CA3106309A1 (en) | 2020-01-23 |
| KR20210045390A (ko) | 2021-04-26 |
| ZA202100513B (en) | 2022-07-27 |
| JP2021530535A (ja) | 2021-11-11 |
| ES2932290T3 (es) | 2023-01-17 |
| EP3823960A1 (en) | 2021-05-26 |
| WO2020016801A1 (en) | 2020-01-23 |
| LT3823960T (lt) | 2022-12-27 |
| CN112424173A (zh) | 2021-02-26 |
| HUE060708T2 (hu) | 2023-04-28 |
| EP3823960B1 (en) | 2022-09-14 |
| SI3823960T1 (sl) | 2023-04-28 |
| IT201800007265A1 (it) | 2020-01-17 |
| RS63854B1 (sr) | 2023-01-31 |
| BR112021000913A2 (pt) | 2021-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019550050A1 (en) | Isoxazole analogs as fxr agonists and methods of use thereof | |
| JOP20200154A1 (ar) | مركبات ومشتقات بيريدو بيريمينون بها استبدال ببنزيل أمينو جديدة كمثبطات sos1 | |
| PH12017500941A1 (en) | Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof | |
| PH12018502268A1 (en) | Amide-substituted pyridinyltriazole derivatives and uses thereof | |
| PH12017500583A1 (en) | Dihydropyrrolopyridine inhibitors of ror-gamma | |
| PH12018500259A1 (en) | Muscarinic agonists | |
| SA518392101B1 (ar) | ROR-Gamma مشتقات البنزيميدازول في صورة مُعدلات لـ | |
| MY192717A (en) | Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof | |
| PH12016501457B1 (en) | Dihydropyrrolopyridine inhibitors of ror-gamma | |
| MX2018006217A (es) | Agonistas del receptor de apelina y metodos de uso. | |
| NZ733174A (en) | Quinazoline derivatives used to treat hiv | |
| EA033343B1 (ru) | Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой | |
| MA40893A (fr) | Dérivés de phényltriazole à substitution hydroxyalkyle et utilisations associées | |
| TW201613880A (en) | Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole | |
| MX2020010674A (es) | Agonistas del receptor muscarinico. | |
| MX2016012574A (es) | Compuestos heteroarilo sustituidos y metodos de uso. | |
| PH12016501619A1 (en) | Substituted fused heterocycles as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | |
| EA201692260A1 (ru) | Соединения 1,3,4-тиадиазола и их применение в лечении рака | |
| EA201792341A1 (ru) | Производные пиразола, пригодные в качестве ингибиторов белка, активирующего 5-липоксигеназу (flap) | |
| MX2019006863A (es) | Inhibidores de heparanasa y uso de los mismos. | |
| EA202191115A1 (ru) | Новые пиридазины | |
| PH12021550143A1 (en) | Pyridopyrimidines as histamine h4-receptor inhibitors | |
| PH12016502480A1 (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
| WO2017168454A3 (en) | Novel compounds as btk inhibitors | |
| MX2021000475A (es) | Isoxazol como agonista del receptor fxr. |